Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Enzo Biochem, Inc. (ENZ)

NYSE - Nasdaq Real Time Price. Currency in USD
1.4300+0.0600 (+4.38%)
At close: 04:00PM EST
1.4300 -0.01 (-0.69%)
After hours: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.3700
Open1.3650
Bid0.0000 x 800
Ask0.0000 x 1100
Day's Range1.3600 - 1.4600
52 Week Range1.1100 - 3.5100
Volume323,859
Avg. Volume70,342
Market Cap69.67M
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-0.2300
Earnings DateMar 13, 2023 - Mar 17, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Insider Monkey

    Enzo Biochem, Inc. (NYSE:ENZ) Q1 2023 Earnings Call Transcript

    Enzo Biochem, Inc. (NYSE:ENZ) Q1 2023 Earnings Call Transcript December 13, 2022 Operator: Greetings and welcome to the Enzo Biochem, Incorporated First Quarter 2023 Earnings Call. At this all participants are in a listen-only mode. . Please note that this conference is being recorded. At this time I will turn the conference over to Brendan […]

  • GlobeNewswire

    Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update

    - Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory services including the evaluation of strategic alternatives for the Company is progressing well. - Continuing to make progress in market expansion of the current product portfolio, commercialization of the Company’s offerings, and optimization of the clinical service segment. Conference call and live webcast scheduled for tomorrow, Tuesday, December

  • GlobeNewswire

    Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th

    Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report first quarter fiscal 2023 financial and operating results after the market close on Monday, December 12, 2022. The Form 10-Q filing will be followed by a live audio webcast and conference call the next day at 8:30 AM ET. To participate in the conference call, please dia

Advertisement
Advertisement